Efficacy and Safety of Cetuximab Plus Cisplatin Alone or in Combination With Paclitaxel in Patients With Head and Neck Squamous Cell Carcinoma: A Randomized Trial

OBJECTIVES: The aim of this study was to assess the clinical usefulness of cetuximab and cisplatin alone or in combination with paclitaxel as the first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). METHODOLOGY: Three hundred patients with conf...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yanqing, Dou, Huiqin, Li, Qingchen, Sun, Ying, Wang, Yanchao, Zhang, Wendong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Advances in Diagnosis and Management of Head and Neck Carcinomas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204453/
https://www.ncbi.nlm.nih.gov/pubmed/34029149
http://dx.doi.org/10.1177/1073274821997444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204453/
https://www.ncbi.nlm.nih.gov/pubmed/34029149
http://dx.doi.org/10.1177/1073274821997444

Ejemplares similares